Preeti Pawaskar

Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis

P. Roy, S. Kannan, S. Gujral, 2013, Indian Journal of Medical and Paediatric Oncology.

Outcomes of COVID-19 and risk factors in patients with cancer

P. Chaturvedi, J. Divatia, C. Pramesh, 2022, Nature Cancer.

Outcomes of COVID-19 and risk factors in patients with cancer - a cohort study

P. Chaturvedi, J. Divatia, C. Pramesh, 2021 .